Cargando…

Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production

Ribavirin is used as a component of combination therapies for the treatment of chronic hepatitis C virus (HCV) infection together with pegylated interferon and/or direct-acting antiviral drugs. Its mechanism of action, however, is not clear. Direct antiviral activity and immunomodulatory functions h...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, McGivern, David R, Cheng, Liang, Li, Guangming, Lemon, Stanley M, Niu, Junqi, Su, Lishan, Reszka-Blanco, Natalia J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537094/
https://www.ncbi.nlm.nih.gov/pubmed/26274905
http://dx.doi.org/10.1371/journal.pone.0135232
_version_ 1782385846005006336
author Wang, Yang
McGivern, David R
Cheng, Liang
Li, Guangming
Lemon, Stanley M
Niu, Junqi
Su, Lishan
Reszka-Blanco, Natalia J
author_facet Wang, Yang
McGivern, David R
Cheng, Liang
Li, Guangming
Lemon, Stanley M
Niu, Junqi
Su, Lishan
Reszka-Blanco, Natalia J
author_sort Wang, Yang
collection PubMed
description Ribavirin is used as a component of combination therapies for the treatment of chronic hepatitis C virus (HCV) infection together with pegylated interferon and/or direct-acting antiviral drugs. Its mechanism of action, however, is not clear. Direct antiviral activity and immunomodulatory functions have been implicated. Plasmacytoid dendritic cells (pDCs) are the principal source of type 1 interferon during viral infection. The interaction of pDCs with HCV-infected hepatocytes is the subject of intense recent investigation, but the effect of ribavirin on pDC activation has not been evaluated. In this study we showed that ribavirin augments toll-like receptors 7 and 9-mediated IFNα/β expression from pDCs and up-regulated numerous interferon-stimulated genes. Using the H77S.3 HCV infection and replication system, we showed that ribavirin enhanced the ability of activated pDCs to inhibit HCV replication, correlated with elevated induction of IFNα. Our findings provide novel evidence that ribavirin contributes to HCV inhibition by augmenting pDCs-derived type 1 IFN production.
format Online
Article
Text
id pubmed-4537094
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45370942015-08-20 Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production Wang, Yang McGivern, David R Cheng, Liang Li, Guangming Lemon, Stanley M Niu, Junqi Su, Lishan Reszka-Blanco, Natalia J PLoS One Research Article Ribavirin is used as a component of combination therapies for the treatment of chronic hepatitis C virus (HCV) infection together with pegylated interferon and/or direct-acting antiviral drugs. Its mechanism of action, however, is not clear. Direct antiviral activity and immunomodulatory functions have been implicated. Plasmacytoid dendritic cells (pDCs) are the principal source of type 1 interferon during viral infection. The interaction of pDCs with HCV-infected hepatocytes is the subject of intense recent investigation, but the effect of ribavirin on pDC activation has not been evaluated. In this study we showed that ribavirin augments toll-like receptors 7 and 9-mediated IFNα/β expression from pDCs and up-regulated numerous interferon-stimulated genes. Using the H77S.3 HCV infection and replication system, we showed that ribavirin enhanced the ability of activated pDCs to inhibit HCV replication, correlated with elevated induction of IFNα. Our findings provide novel evidence that ribavirin contributes to HCV inhibition by augmenting pDCs-derived type 1 IFN production. Public Library of Science 2015-08-14 /pmc/articles/PMC4537094/ /pubmed/26274905 http://dx.doi.org/10.1371/journal.pone.0135232 Text en © 2015 Wang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Wang, Yang
McGivern, David R
Cheng, Liang
Li, Guangming
Lemon, Stanley M
Niu, Junqi
Su, Lishan
Reszka-Blanco, Natalia J
Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production
title Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production
title_full Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production
title_fullStr Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production
title_full_unstemmed Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production
title_short Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production
title_sort ribavirin contributes to hepatitis c virus suppression by augmenting pdc activation and type 1 ifn production
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537094/
https://www.ncbi.nlm.nih.gov/pubmed/26274905
http://dx.doi.org/10.1371/journal.pone.0135232
work_keys_str_mv AT wangyang ribavirincontributestohepatitiscvirussuppressionbyaugmentingpdcactivationandtype1ifnproduction
AT mcgiverndavidr ribavirincontributestohepatitiscvirussuppressionbyaugmentingpdcactivationandtype1ifnproduction
AT chengliang ribavirincontributestohepatitiscvirussuppressionbyaugmentingpdcactivationandtype1ifnproduction
AT liguangming ribavirincontributestohepatitiscvirussuppressionbyaugmentingpdcactivationandtype1ifnproduction
AT lemonstanleym ribavirincontributestohepatitiscvirussuppressionbyaugmentingpdcactivationandtype1ifnproduction
AT niujunqi ribavirincontributestohepatitiscvirussuppressionbyaugmentingpdcactivationandtype1ifnproduction
AT sulishan ribavirincontributestohepatitiscvirussuppressionbyaugmentingpdcactivationandtype1ifnproduction
AT reszkablanconataliaj ribavirincontributestohepatitiscvirussuppressionbyaugmentingpdcactivationandtype1ifnproduction